• -
414 Results
Telemedicine
Best Practices for Using Health Education to Change Behavior
Though health education cost-effectively reduces the incidence, morbidity and mortality of chronic conditions such as obesity, currently there is no consistent, systematic method by which Americans are educated about their health. This paper discusses proven approaches to positively change poor behaviors such as overeating and a sedentary lifestyle — key factors that lead to obesity. Health problems related to obesity are thereby reduced, cutting health care costs.
Quianta Moore, Ashleigh Johnson April 30, 2015
Genome
Economic Perspective on Genomic Testing: Is It Worth the Cost?
Genomic testing is a rapidly growing field, especially in cancer medicine, where it can be used to match patients to the most effective targeted treatment. In the past decade, we have seen rapid growth in the number of new genomic tests that are available. However, genomic testing is usually very expensive, raising the question of whether the testing is worth the cost.
Chan Shen March 25, 2015
Map of Middle East.
Cord Blood Banking in the Arab World: Current Status and Future Developments
In addition to their therapeutic potential, cord blood banks raise ethical and regulatory questions, especially in emerging markets in the Arab world. In this article, the authors review cord blood banking in five countries in the region (Jordan, Saudi Arabia, Egypt, Qatar, and the United Arab Emirates) that were selected for their different CB banking policies and initiatives.
Monica M. Matsumoto, Rana Dajani, Kirstin R.W. Matthews February 13, 2015
RX Medicine
Viewpoints: The Future of Treatment in Drug Policy
Drug policy has experienced an interesting shift recently. Along with legalization of medical and recreational marijuana, many states are also reducing penalties for nonviolent drug offenses and placing greater focus on treatment for drug users. The emphasis on treatment and rehabilitation for drug users is the result of many factors, including recognition that the drug war has not reduced drug use, a desire to reduce the prison population and save money, and a surge in the rate of overdoses from opioid and heroin use. What remains to be seen is whether the current popularity of drug treatment will become a more permanent feature of drug policy. In this Baker Institute Viewpoints series, five experts on drug policy examine the question, “Is the current emphasis on treatment in drug policy a short-term trend or is it here to stay?”
Katharine Neill Harris, William Martin December 19, 2014